Fuminori Sakurai

6.6k total citations
182 papers, 5.2k citations indexed

About

Fuminori Sakurai is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Fuminori Sakurai has authored 182 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 116 papers in Genetics and 40 papers in Oncology. Recurrent topics in Fuminori Sakurai's work include Virus-based gene therapy research (113 papers), RNA Interference and Gene Delivery (49 papers) and Viral gastroenteritis research and epidemiology (39 papers). Fuminori Sakurai is often cited by papers focused on Virus-based gene therapy research (113 papers), RNA Interference and Gene Delivery (49 papers) and Viral gastroenteritis research and epidemiology (39 papers). Fuminori Sakurai collaborates with scholars based in Japan, France and United States. Fuminori Sakurai's co-authors include Hiroyuki Mizuguchi, Kenji Kawabata, Takao Hayakawa, Masashi Tachibana, Kazuo Takayama, Katsuhisa Tashiro, Yasuhito Nagamoto, Kazufumi Katayama, Miho Furue and Teruhide Yamaguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Fuminori Sakurai

181 papers receiving 5.1k citations

Peers

Countries citing papers authored by Fuminori Sakurai

Since Specialization

Citations

This map shows the geographic impact of Fuminori Sakurai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminori Sakurai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminori Sakurai more than expected).

Fields of papers citing papers by Fuminori Sakurai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminori Sakurai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminori Sakurai. The network helps show where Fuminori Sakurai may publish in the future.

Co-authorship network of co-authors of Fuminori Sakurai

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminori Sakurai. A scholar is included among the top collaborators of Fuminori Sakurai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminori Sakurai. Fuminori Sakurai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Masashi Tachibana, Ken J. Ishii, Fuminori Sakurai, Hiroyuki Mizuguchi	0
2	Small extracellular vesicles carrying reovirus, tumor antigens, interferon-β, and damage-associated molecular patterns for efficient tumor treatment 2024 ·Journal of Controlled Release ·(unknown), Chieko Inoue, (unknown), Kentaro Jingushi, (unknown), Shigeru Kawakami, Kazutake Tsujikawa, Masashi Tachibana, Hiroyuki Mizuguchi, Fuminori Sakurai	8
3	Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6/7 regions of adenovirus serotype 5 2024 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), Masashi Tachibana, Fuminori Sakurai, Hiroyuki Mizuguchi	1
4	Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes 2023 ·Journal of Controlled Release ·(unknown), (unknown), (unknown), (unknown), (unknown), Masashi Tachibana, Masato Tanuma, Atsushi Kasai, Hitoshi Hashimoto, Ken‐ichi Ogawara, Hiroyuki Mizuguchi, Fuminori Sakurai	16
5	Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism 2022 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), (unknown), Fuminori Sakurai, Hiroyuki Mizuguchi, Daisuke Okuzaki, Naoki Okada, Masashi Tachibana	5
6	Adenovirus vector-based vaccine for infectious diseases 2021 ·Drug Metabolism and Pharmacokinetics ·Fuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi	87
7	Oncolytic Reovirus Inhibits Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in a TLR3-Dependent Manner 2018 ·The Journal of Immunology ·Yuki Katayama, Masashi Tachibana, (unknown), (unknown), (unknown), (unknown), Kouji Kobiyama, Ken J. Ishii, Shizuo Akira, Hiroyuki Mizuguchi, Fuminori Sakurai	34
8	Nanaomycin A Treatment Promotes Hepatoblast Differentiation from Human iPS Cells 2018 ·Stem Cells and Development ·(unknown), (unknown), Kazuo Takayama, Fuminori Sakurai, Hiroyuki Mizuguchi	11
9	Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer 2016 ·Molecular Cancer Therapeutics ·Mitsuhiro Machitani, Fuminori Sakurai, (unknown), Masashi Tachibana, Toshiyoshi Fujiwara, Hiroyuki Mizuguchi	19
10	Reovirus double-stranded RNA genomes and polyI:C induce down-regulation of hypoxia-inducible factor 1α 2015 ·Biochemical and Biophysical Research Communications ·(unknown), Masashi Tachibana, Hiroyuki Mizuguchi, Fuminori Sakurai	7
11	Evaluation of Transduction Properties of an Adenovirus Vector in Neonatal Mice 2015 ·BioMed Research International ·(unknown), Fuminori Sakurai, Kahori Shimizu, Kazuo Ohashi, Shinichiro Nakamura, Masashi Tachibana, Hiroyuki Mizuguchi	6
12	Proteolytic Disassembly of Viral Outer Capsid Proteins Is Crucial for Reovirus-Mediated Type-I Interferon Induction in Both Reovirus-Susceptible and Reovirus-Refractory Tumor Cells 2015 ·BioMed Research International ·Yuki Katayama, (unknown), Masashi Tachibana, Hiroyuki Mizuguchi, Fuminori Sakurai	9
13	The Early Activation ofCD8+T Cells Is Dependent on Type I IFN Signaling following Intramuscular Vaccination of Adenovirus Vector 2014 ·BioMed Research International ·(unknown), Masashi Tachibana, (unknown), Masaki Shoji, Fuminori Sakurai, Kenji Kawabata, Kouji Kobiyama, Ken J. Ishii, Shizuo Akira, Hiroyuki Mizuguchi	7
14	Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs 2013 ·Virus Research ·Mitsuhiro Machitani, Fuminori Sakurai, (unknown), Masashi Tachibana, Takayuki Suzuki, Hayato Matsui, Teruhide Yamaguchi, Hiroyuki Mizuguchi	15
15	Inhibition of Lnk in Mouse Induced Pluripotent Stem Cells Promotes Hematopoietic Cell Generation 2012 ·Stem Cells and Development ·Katsuhisa Tashiro, Miyuki Omori, Kenji Kawabata, (unknown), Tomoko Yamaguchi, Fuminori Sakurai, Satoshi Τακακι, Hiroyuki Mizuguchi	2
16	Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a 2012 ·Virus Research ·Fuminori Sakurai, (unknown), Maiko Higuchi, (unknown), Kaori Ono, Takeshi Yoshida, Masuo Kondoh, Kiyohito Yagi, Naoya Sakamoto, Kazufumi Katayama, Hiroyuki Mizuguchi	17
17	Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences 2011 ·Clinical Cancer Research ·(unknown), Fuminori Sakurai, Kazufumi Katayama, Katsuhisa Tashiro, Hayato Matsui, Kenji Kawabata, Atsushi Kawase, Masahiro Iwaki, Takao Hayakawa, Toshiyoshi Fujiwara, Hiroyuki Mizuguchi	34
18	miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy 2008 ·Molecular Therapy ·(unknown), Fuminori Sakurai, Shinichiro Nakamura, (unknown), Kenji Kawabata, Masuo Kondoh, Kiyohito Yagi, Hiroyuki Mizuguchi	62
19	Fiber-Modified Adenovirus Vectors Decrease Liver Toxicity through Reduced IL-6 Production 2007 ·The Journal of Immunology ·Naoya Koizumi, Tomoko Yamaguchi, Kenji Kawabata, Fuminori Sakurai, Tomomi Sasaki, Yoshiteru Watanabe, Takao Hayakawa, Hiroyuki Mizuguchi	67
20	Downregulation of human CD46 by adenovirus serotype 35 vectors 2007 ·Gene Therapy ·Fuminori Sakurai, (unknown), Kenji Kawabata, T. Hayakawa, Hiroyuki Mizuguchi	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact